P170 - Complex perianal fistulas in Crohn's disease: infliximab, surgery or combined approach

P169 Higher remission rates in patients with once-daily dosing compared to twice-daily dosing. An analysis of compliance in the once daily vs. twice daily podium trial with mesalazine (Pentasa®) sachets B. Bokemeyer1 *, A. Dignass2, T. Stijnen3, H. Veerman4. 1Gastroenterologische Gemeinschaftspraxis, Minden, Germany, 2Markus-Krankenhaus, Frankfurt/ Main, Germany, 3University Leiden, Leiden, Netherlands, 4Ferring Pharmaceuticals, Hoofddorp, Netherlands